Yayıncı "Walter de Gruyter GMBH" için listeleme
Toplam kayıt 3, listelenen: 1-3
-
Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents?
(Walter de Gruyter GMBH, 2020)Objectives: Copeptin, the C-terminal part of arginine-vasopressin, is increased in hypertensive adolescents and closely associated with metabolic syndrome (MS). We aimed to investigate whether serum copeptin can be used ... -
Patient-specific induced pluripotent stem cells for cardiac disease modeling
(Walter de Gruyter GMBH, 2019)Reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) via induction of pluripotency genes is one of the most influential scientific breakthroughs during the last decade. Behind this breakthrough ... -
Possible effects of neonatal vitamin B12 status on TSH-screening program: A cross-sectional study from Turkey
(Walter de Gruyter GMBH, 2017)Background: In this study we evaluated whether vitamin B12 deficiency affects neonatal screening (NS) for congenital hypothyroidism (CH). Methods: A cross-sectional study conducted from 2010 to 2011. A total of 10,740 ...